Table 4.
BCC subtypes distribution.
| BCC subtype | n (%) | ||||
|---|---|---|---|---|---|
| Cancer history | Immunosuppressants | DM | CKD | Chronic infections | |
| Infiltrative | — | 1 (6.25%) | 10 (14.71%) | 1 (7.69%) | 1 (7.14%) |
| Nodular | 16 (34.04%) | 1 (6.25%) | 16 (23.53%) | 2 (15.38%) | — |
| Pigmented | 1 (2.13%) | — | 5 (7.35%) | — | — |
| Superficial | 17 (36.17%) | 10 (62.5%) | 22 (32.35%) | 5 (38.46%) | 11 (78.57%) |
| Ulcerated | 10 (21.28%) | 1 (6.25%) | 11 (16.18%) | 5 (38.46%) | 1 (7.14%) |
| Other | 3 (6.38%) | 3 (18.75%) | 4 (5.88%) | — | 1 (7.14%) |
CKD, chronic kidney disease; DM, diabetes mellitus.